These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38377327)

  • 1. Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System.
    Petrovski G; Campbell J; Pasha M; Hussain K; Khalifa A; Umer F; Almajaly D; Hamdar M; Heuvel TVD; Edd SN
    Diabetes Technol Ther; 2024 Mar; 26(S3):76-83. PubMed ID: 38377327
    [No Abstract]   [Full Text] [Related]  

  • 2. Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents With Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control.
    Petrovski G; Campbell J; Pasha M; Day E; Hussain K; Khalifa A; van den Heuvel T
    Diabetes Care; 2023 Mar; 46(3):544-550. PubMed ID: 36598841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.
    Cordero TL; Dai Z; Arrieta A; Niu F; Vella M; Shin J; Rhinehart AS; McVean J; Lee SW; Slover RH; Forlenza GP; Shulman DI; Pop-Busui R; Thrasher JR; Kipnes MS; Christiansen MP; Buckingham BA; Pihoker C; Sherr JL; Kaiserman KB; Vigersky RA
    Diabetes Technol Ther; 2023 Sep; 25(9):652-658. PubMed ID: 37252734
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes.
    Piccini B; Pessina B; Casalini E; Lenzi L; Toni S
    Pediatr Diabetes; 2022 Dec; 23(8):1647-1655. PubMed ID: 36317539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control.
    Lombardo F; Passanisi S; Alibrandi A; Bombaci B; Bonfanti R; Delvecchio M; Di Candia F; Mozzillo E; Piccinno E; Piona CA; Rigamonti A; Scialabba F; Maffeis C; Salzano G
    Diabetes Technol Ther; 2023 Jun; 25(6):404-413. PubMed ID: 36763343
    [No Abstract]   [Full Text] [Related]  

  • 6. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol.
    Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K
    BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Glycemic Outcomes During the MiniMed
    Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.
    Elbarbary NS; Ismail EAR
    Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System.
    Shalit R; Minsky N; Laron-Hirsh M; Cohen O; Kurtz N; Roy A; Grosman B; Benedetti A; Tirosh A
    Diabetes Technol Ther; 2023 Sep; 25(9):579-588. PubMed ID: 37335759
    [No Abstract]   [Full Text] [Related]  

  • 10. A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology.
    Grosman B; Roy A; Lintereur L; Turksoy K; Benedetti A; Cordero TL; Vigersky RA; McVean J; Rhinehart AS; Cohen O
    Diabetes Technol Ther; 2024 Mar; 26(S3):17-23. PubMed ID: 38377324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-Month Effectiveness of Advanced
    Tornese G; Buzzurro F; Carletti C; Faleschini E; Barbi E
    Front Endocrinol (Lausanne); 2021; 12():766314. PubMed ID: 34858339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
    Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
    Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
    Haidar A; Yale JF; Lovblom LE; Cardinez N; Orszag A; Falappa CM; Gouchie-Provencher N; Tsoukas MA; El Fathi A; Rene J; Eldelekli D; Lanctôt SO; Scarr D; Perkins BA
    Diabetes Obes Metab; 2021 Jun; 23(6):1272-1281. PubMed ID: 33528904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.
    Lepore G; Rossini A; Bellante R; Corsi A; Scaranna C; Dodesini AR; Trevisan R
    Acta Diabetol; 2022 Oct; 59(10):1309-1315. PubMed ID: 35857108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.
    Thrasher JR; Arrieta A; Niu F; Cameron KR; Cordero TL; Shin J; Rhinehart AS; Vigersky RA
    Diabetes Technol Ther; 2024 Mar; 26(S3):24-31. PubMed ID: 38377317
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
    Carlson AL; Sherr JL; Shulman DI; Garg SK; Pop-Busui R; Bode BW; Lilenquist DR; Brazg RL; Kaiserman KB; Kipnes MS; Thrasher JR; Reed JHC; Slover RH; Philis-Tsimikas A; Christiansen M; Grosman B; Roy A; Vella M; Jonkers RAM; Chen X; Shin J; Cordero TL; Lee SW; Rhinehart AS; Vigersky RA
    Diabetes Technol Ther; 2022 Mar; 24(3):178-189. PubMed ID: 34694909
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy.
    Lepore G; Borella ND; Castagna G; Ippolito S; Bonfadini S; Corsi A; Scaranna C; Dodesini AR; Bellante R; Trevisan R
    Diabetes Technol Ther; 2024 Jan; 26(1):49-58. PubMed ID: 37902785
    [No Abstract]   [Full Text] [Related]  

  • 18. The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment.
    Quirós C; Alonso-Carril N; Rodríguez-Rodríguez S; Barahona MJ; Orois A; Simó-Servat A; Ramos M; Perea V
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Feb; 70(2):130-135. PubMed ID: 36925230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery System.
    O'Neal DN; Zaharieva DP; Morrison D; McCarthy O; Nørgaard K
    Diabetes Technol Ther; 2024 Mar; 26(S3):84-96. PubMed ID: 38377316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Follow-Up of Advanced Hybrid Closed-Loop System in Adults with Type 1 Diabetes Previously Naive to Diabetes Technology: The Effect of Switching to a Calibration-Free Sensor.
    Matejko B; Juza A; Kieć-Wilk B; Cyranka K; Krzyżowska S; Cohen O; Malecki MT; Klupa T
    Diabetes Technol Ther; 2023 Aug; 25(8):554-558. PubMed ID: 37184526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.